1. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals.
- Author
-
Addo MM, Altfeld M, Rosenberg ES, Eldridge RL, Philips MN, Habeeb K, Khatri A, Brander C, Robbins GK, Mazzara GP, Goulder PJ, and Walker BD
- Subjects
- CD8-Positive T-Lymphocytes immunology, Epitopes, T-Lymphocyte immunology, HIV Infections blood, Humans, Longitudinal Studies, Peptides immunology, rev Gene Products, Human Immunodeficiency Virus, tat Gene Products, Human Immunodeficiency Virus, Gene Products, rev immunology, Gene Products, tat immunology, HIV Infections immunology, HIV-1 immunology, T-Lymphocytes, Cytotoxic immunology
- Abstract
The HIV-1 regulatory proteins Rev and Tat are expressed early in the virus life cycle and thus may be important targets for the immune control of HIV-1-infection and for effective vaccines. However, the extent to which these proteins are targeted in natural HIV-1 infection as well as precise epitopes targeted by human cytotoxic T lymphocytes (CTL) remain to be defined. In the present study, 57 HIV-1-infected individuals were screened for responses against Tat and Rev by using overlapping peptides spanning the entire Tat and Rev proteins. CD8+ T cell responses against Tat and Rev were found in up to 19 and 37% of HIV-1-infected individuals, respectively, indicating that these regulatory proteins are important targets for HIV-1-specific CTL. Despite the small size of these proteins, multiple CTL epitopes were identified in each. These data indicate that Tat and Rev are frequently targeted by CTL in natural HIV-1 infection and may be important targets for HIV vaccines.
- Published
- 2001
- Full Text
- View/download PDF